Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag crawled time : 08:20 save search
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published: 2023-11-25 (Crawled : 08:20) - prnewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
| Email alert
Add to watchlist
ELAN | $13.605 5.22% 2.2M
|
Process Industries
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 490
|
Health Technology
| Email alert
Add to watchlist
ZTS | $149.5 2.72% 1.9M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.16 130
|
Communications
| Email alert
Add to watchlist
vaccine reach research market
ALERT: The M&A Class Action Firm Continues Investigating the Merger - PRTK, KDNY, BG, WTT
Published: 2023-06-17 (Crawled : 08:20) - prnewswire.com
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 490
|
Health Technology
| Email alert
Add to watchlist
PRTK | $2.23 0.0% 4.8M
|
Health Technology
| Email alert
Add to watchlist
BG | $109.5 -0.23% 720K
|
Process Industries
| Email alert
Add to watchlist
Novartis Cosentyx® shows clinically meaningful symptom improvements in patients with hidradenitis suppurativa in pivotal Phase III trials
Published: 2022-09-10 (Crawled : 08:20) - globenewswire.com
NVSEF | News | $95.11 490
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
| Email alert
Add to watchlist
cosentyx trials novartis
INVESTOR DEADLINE: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLN
Published: 2022-07-16 (Crawled : 08:20) - prnewswire.com
AMGN | News | $273.38 0.54% 790K
|
Health Technology
| Email alert
Add to watchlist
MOLN | $3.88 470
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 490
|
Health Technology
| Email alert
Add to watchlist
molecular
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.